{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:12:25Z","timestamp":1791850345211,"version":"4.3.4"},"reference-count":127,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.jaad.2005.07.073","type":"journal-article","created":{"date-parts":[[2007,6,16]],"date-time":"2007-06-16T10:11:17Z","timestamp":1181988677000},"page":"1-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":325,"title":["Psoriasis of the nail: Anatomy, pathology, clinical\u00a0presentation, and a review of the literature on therapy"],"prefix":"10.1016","volume":"57","author":[{"given":"Michael M.","family":"Jiaravuthisan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Sasseville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald B.","family":"Vender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channy Y.","family":"Muhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2005.07.073_bib1","unstructured":"National Psoriasis Foundation. Benchmark survey on psoriasis and psoriatic arthritis. Summary of top-line results. Available at: http:\/\/www.psoriasis.org\/files\/pdfs\/press\/npfsurvey.pdf. Accessed August 21, 2004."},{"key":"10.1016\/j.jaad.2005.07.073_bib2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0733-8635(05)70376-4","article-title":"Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment","volume":"14","author":"Koo","year":"1996","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2005.07.073_bib3","unstructured":"Psoriasis Society of Canada. Telephone interview. Conducted August 11, 2004."},{"key":"10.1016\/j.jaad.2005.07.073_bib4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archderm.1938.01480160075008","article-title":"Psoriasis of the nails","volume":"38","author":"Crawford","year":"1938","journal-title":"Arch Derm Syphilol"},{"key":"10.1016\/j.jaad.2005.07.073_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.1964.tb15505.x","article-title":"The nails in psoriatic arthritis","volume":"76","author":"Baker","year":"1964","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1963.tb13535.x","article-title":"Psoriasis and the nails","volume":"76","author":"Calvert","year":"1963","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib7","unstructured":"Pardo-Castello V, Pardo OA. Diseases of the nails. Springfield, MA: Chas C. Thomas; 1960."},{"key":"10.1016\/j.jaad.2005.07.073_bib8","series-title":"Die krankheiten der nagel","author":"Heller","year":"1900"},{"key":"10.1016\/j.jaad.2005.07.073_bib9","series-title":"The nails in disease, 5th ed","author":"Samman","year":"1994"},{"key":"10.1016\/j.jaad.2005.07.073_bib10","article-title":"Diseases of the nail and their management","author":"Baran","year":"1984"},{"key":"10.1016\/j.jaad.2005.07.073_bib11","series-title":"Nails: therapy, diagnosis, surgery","author":"Scher","year":"2003"},{"key":"10.1016\/j.jaad.2005.07.073_bib12","series-title":"The nail in health and disease, 2nd ed","author":"Zaias","year":"1990"},{"key":"10.1016\/j.jaad.2005.07.073_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/archderm.1969.01610230059011","article-title":"Psoriasis of the nail: a clinical-pathologic study","volume":"99","author":"Zaias","year":"1969","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/jid.1968.103","article-title":"The formation of the primate nail: an autoradiographic study","volume":"51","author":"Zaias","year":"1968","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1963.01590130043010","article-title":"The embryology of the human nail","volume":"87","author":"Zaias","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(01)00989-9","article-title":"Drug delivery to the nail following topical application","volume":"236","author":"Murdan","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jaad.2005.07.073_bib17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-4362.1983.tb02124.x","article-title":"The normal and pathologic nail","volume":"22","author":"Achten","year":"1983","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib18","series-title":"A text atlas of nail disorders. Techniques in investigation and diagnosis, 3rd ed","author":"Baran","year":"2003"},{"key":"10.1016\/j.jaad.2005.07.073_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM197909063011015","article-title":"Cyclosporin A for psoriasis","volume":"301","author":"Mueller","year":"1979","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.jaad.2005.07.073_bib20","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1001\/jama.1986.03380220076026","article-title":"Cyclosporine improves psoriasis in a double-blind study","volume":"256","author":"Ellis","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2005.07.073_bib21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nm0595-442","article-title":"Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis","volume":"1","author":"Gottlieb","year":"1995","journal-title":"Nat Med"},{"issue":"6 pt 1","key":"10.1016\/j.jaad.2005.07.073_bib22","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0190-9622(98)70590-0","article-title":"Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial","volume":"38","author":"Bagel","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","article-title":"The immunologic basis for the treatment of psoriasis with new biologic agents","volume":"46","author":"Krueger","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"suppl","key":"10.1016\/j.jaad.2005.07.073_bib24","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S0190-9622(03)01134-4","article-title":"The immunology of psoriasis and biologic immunotherapy","volume":"49","author":"Mehlis","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib25","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(03)12954-6","article-title":"Psoriasis","volume":"361","author":"Lebwohl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2005.07.073_bib26","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1503\/cmaj.1031335","article-title":"Psoriasis and the new biologic agents: interrupting a T-AP dance","volume":"170","author":"Walsh","year":"2004","journal-title":"CMAJ"},{"issue":"suppl 3","key":"10.1016\/j.jaad.2005.07.073_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/12034754020060S302","article-title":"Pathophysiology of psoriasis: science behind therapy","volume":"6","author":"Guenther","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2005.07.073_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1563-2571.2002.01044.x","article-title":"T lymphocyte activation\u2014an inside overview","volume":"29","author":"Aringer","year":"2002","journal-title":"Acta Med Austriaca"},{"key":"10.1016\/j.jaad.2005.07.073_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1096\/fj.01-0933rev","article-title":"Intercellular transfer of antigen-presenting cell determinants onto T cells\u2014molecular mechanisms and biological significance","volume":"16","author":"Hudrisier","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jaad.2005.07.073_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1471-4906(01)01869-5","article-title":"Interaction of T cells with APCs\u2014the serial encounter model","volume":"22","author":"Friedl","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaad.2005.07.073_bib31","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed\u00a0on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2005.07.073_bib32","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/349796a0","article-title":"ELAM-1 is an adhesion molecule for skin-homing T cells","volume":"349","author":"Picker","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2005.07.073_bib33","first-page":"482","article-title":"Clinical observations on nail changes in psoriasis","volume":"17","author":"Tham","year":"1988","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jaad.2005.07.073_bib34","series-title":"Color atlas & synopsis of clinical dermatology, 4th ed","author":"Fitzpatrick","year":"1990"},{"key":"10.1016\/j.jaad.2005.07.073_bib35","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/00007611-197911000-00022","article-title":"Recurrent atraumatic subungual splinter hemorrhages in healthy individuals","volume":"72","author":"Miller","year":"1979","journal-title":"South Med J"},{"key":"10.1016\/j.jaad.2005.07.073_bib36","series-title":"Endocrinology and metabolism","first-page":"61","article-title":"Hormone action: control of target cell function by peptide, thyroid and steroid hormones","author":"Catt","year":"1981"},{"key":"10.1016\/j.jaad.2005.07.073_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-4731(84)90192-4","article-title":"Mechanisms of glucocorticoid hormone action","volume":"20","author":"Lan","year":"1984","journal-title":"J\u00a0Steroid Biochem"},{"key":"10.1016\/j.jaad.2005.07.073_bib38","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1073\/pnas.79.24.7659","article-title":"Glucocorticoid and thyroid hormones transcriptionally regulate growth hormone gene expression","volume":"79","author":"Evans","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2005.07.073_bib39","doi-asserted-by":"crossref","first-page":"11627","DOI":"10.1016\/S0021-9258(18)33808-0","article-title":"Growth hormone gene transcription is regulated by thyroid and glucocorticoid hormones in cultured rat pituitary tumor cells","volume":"257","author":"Spindler","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2005.07.073_bib40","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1172\/JCI108159","article-title":"Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone","volume":"56","author":"Dale","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2005.07.073_bib41","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM197411282912203","article-title":"Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections","volume":"291","author":"Dale","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2005.07.073_bib42","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1152\/ajplegacy.1966.211.6.1393","article-title":"Role of glucocorticoids in local regulation of blood flow","volume":"211","author":"Altura","year":"1966","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jaad.2005.07.073_bib43","first-page":"423A","article-title":"Inhibition of granulocyte adherence: potential mechanism of action of anti-inflammatory drugs","volume":"22","author":"MacGregor","year":"1974","journal-title":"Clin Res"},{"key":"10.1016\/j.jaad.2005.07.073_bib44","series-title":"Progress in research and clinical applications of corticosteroids","first-page":"14","article-title":"Glucocorticoids and the immune system: activation of glucocorticoid-receptor complexes in thymus cells; modulation of Fc receptors of phagocytic cells","author":"Guyre","year":"1982"},{"key":"10.1016\/j.jaad.2005.07.073_bib45","series-title":"Mechanisms of topical corticosteroid activity","first-page":"39","article-title":"The action of topical steroids on the epidermal cell cycle","author":"Marks","year":"1976"},{"key":"10.1016\/j.jaad.2005.07.073_bib46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.1971.04000130041005","article-title":"The activity of corticosteroids on epidermal mitotic activity","volume":"103","author":"Fisher","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib47","series-title":"Topical corticosteroid therapy: a novel approach to safer drugs","first-page":"57","article-title":"Effects of corticosteroids on human fibroblasts in vitro","author":"Hein","year":"1988"},{"key":"10.1016\/j.jaad.2005.07.073_bib48","series-title":"Topical corticosteroid therapy: a novel approach to safer drugs","first-page":"105","article-title":"Survey of methods for assessment of corticosteroid atrophogenicity","author":"Marks","year":"1988"},{"key":"10.1016\/j.jaad.2005.07.073_bib49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1067\/mjd.2001.117046","article-title":"Treatment of psoriasis. Part 1. Topical therapy and phototherapy","volume":"45","author":"Lebwohl","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib50","first-page":"S72","article-title":"The future of vitamin D in dermatology","volume":"37","author":"Kragbelle","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2133.1998.02029.x","article-title":"Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels with lesions","volume":"138","author":"Kang","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib52","series-title":"Comprehensive dermatologic drug therapy","author":"Wolverton","year":"2001"},{"key":"10.1016\/j.jaad.2005.07.073_bib53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000029803","article-title":"An update on vitamin D3 analogues in the treatment of psoriasis","volume":"11","author":"van der Kerkhof","year":"1998","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"10.1016\/j.jaad.2005.07.073_bib54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2230.2000.00663.x","article-title":"Management of nail psoriasis","volume":"25","author":"de Berker","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib55","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2133.1998.02462.x","article-title":"Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid","volume":"139","author":"Tosti","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib56","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00015550252948220","article-title":"Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream","volume":"82","author":"Rigopoulos","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2005.07.073_bib57","first-page":"300","article-title":"Corticosteroid-induced \u2018disappearing digit\u2019","volume":"126","author":"Wolf","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib58","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archderm.1990.01670320033003","article-title":"Acroatrophy secondary to long-standing applications of topical steroids","volume":"126","author":"Requena","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib59","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.1987.91660010035013","article-title":"Distal phalangeal atrophy secondary to\u00a0topical steroid therapy","volume":"123","author":"Deffer","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib60","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0190-9622(99)70114-3","article-title":"A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses","volume":"41","author":"Kurwa","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"2 part 1","key":"10.1016\/j.jaad.2005.07.073_bib61","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0190-9622(97)70287-1","article-title":"Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin","volume":"36","author":"Sander","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1524-4725.1997.tb00020.x","article-title":"Long-term efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs. 5% 5-fluorouracil in the treatment of widespread facial actinic keratroses","volume":"23","author":"Witheiler","year":"1997","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2005.07.073_bib63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archderm.1995.01690140060009","article-title":"A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs. fluorouracil in the treatment of widespread facial actinic keratoses","volume":"131","author":"Lawrence","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib64","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1524-4725.1995.tb00132.x","article-title":"Short-term intensive 5-fluorouracil treatment of actinic keratoses","volume":"21","author":"Unis","year":"1995","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2005.07.073_bib65","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0190-9622(91)70250-6","article-title":"Weekly pulse dosing: effective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratoses","volume":"25","author":"Pearlman","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib66","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.1987.tb05876.x","article-title":"Topical chemotherapy of actinic keratoses of\u00a0the upper extremity with tretinoin and 5-fluorouracil: a\u00a0double-blind controlled study","volume":"116","author":"Bercovitch","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib67","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archderm.1963.01590210005001","article-title":"Selective effect of topical 5-fluorouracil","volume":"88","author":"Dillaha","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib68","first-page":"81","article-title":"Tumors of the skin. I. Effects of local use of cytostatic agents","volume":"1","author":"Klein","year":"1962","journal-title":"Skin (Los Angeles)"},{"key":"10.1016\/j.jaad.2005.07.073_bib69","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archderm.1974.01630110033006","article-title":"Topically applied fluorouracil in the treatment of psoriatic nails","volume":"110","author":"Fredriksson","year":"1974","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib70","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000018281","article-title":"Dystrophic psoriatic fingernails treated with\u00a01%\u00a05-fluorouracil in a nail penetration-enhancing vehicle:\u00a0a\u00a0double-blind study","volume":"199","author":"de Jong","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2005.07.073_bib71","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.4049\/jimmunol.156.11.4514","article-title":"Anti-psoriatic drug anthralin activates transcription factor NF-kappa B in murine keratinocytes","volume":"156","author":"Schmidt","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2005.07.073_bib72","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2133.1992.tb00458.x","article-title":"Inhibition of human monocyte functions by anthralin","volume":"127","author":"Mrowietz","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000210836","article-title":"Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris","volume":"3","author":"Kemeny","year":"1990","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.jaad.2005.07.073_bib74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/1523-1747.ep12537586","article-title":"Inhibition of a Langerhans cell-mediated immune response by treatment modalities useful in psoriasis","volume":"81","author":"Morhenn","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib75","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1346-8138.1998.tb02386.x","article-title":"Topical anthralin therapy for refractory nail psoriasis","volume":"25","author":"Yamamoto","year":"1998","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib76","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1357-2725(96)00101-X","article-title":"Retinoid X receptors","volume":"29","author":"Rowe","year":"1997","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jaad.2005.07.073_bib77","first-page":"15","article-title":"Pharmacology and molecular action of retinoids and vitamin D in skin","volume":"1","author":"Kang","year":"1996","journal-title":"J Invest Dermatol Symposium Proc"},{"key":"10.1016\/j.jaad.2005.07.073_bib78","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1159\/000248850","article-title":"Clinical pharmacology of 3 generations of retinoids","volume":"175","author":"Vahlquist","year":"1987","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2005.07.073_bib79","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-4362.2001.01167.x","article-title":"Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis","volume":"40","author":"Koo","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib80","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1067\/mjd.2000.108320","article-title":"Tazarotene combination treatments in psoriasis","volume":"43","author":"Guenther","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib81","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1067\/mjd.2000.107940","article-title":"Tazarotene plus UVB phototherapy in the treatment of psoriasis","volume":"43","author":"Koo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib82","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0190-9622(98)70008-8","article-title":"Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis","volume":"39","author":"Lebwohl","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"suppl","key":"10.1016\/j.jaad.2005.07.073_bib83","first-page":"S30","article-title":"Excerpt of panel discussion from symposium","volume":"61","year":"1998","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2005.07.073_bib84","first-page":"355","article-title":"Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study","volume":"68","author":"Scher","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2005.07.073_bib85","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","article-title":"The mechanism of action of cyclosporine and FK506","volume":"13","author":"Schreiber","year":"1992","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaad.2005.07.073_bib86","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/352803a0","article-title":"Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporine","volume":"352","author":"Flanagan","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2005.07.073_bib87","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin and FKPP-FK5-6 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2005.07.073_bib88","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1084\/jem.171.2.533","article-title":"The effect of immunosuppressive agents on the induction of nuclear factors that bend to sites on the interleukin-2 promotor","volume":"171","author":"Granelli-Piperno","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2005.07.073_bib89","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0008-8749(83)90265-4","article-title":"Cyclosporin A inhbits the production of gamma interferon (IFN-\u03b3), but does not inhibit production of virus-induced IFN-\u03b3","volume":"78","author":"Kalman","year":"1983","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaad.2005.07.073_bib90","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2133.1987.tb05869.x","article-title":"The effects of cyclosporine A on T-lymphocyte and dendritic cell sub-populations in psoriasis","volume":"116","author":"Baker","year":"1987","journal-title":"Br\u00a0J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib91","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000248005","article-title":"Topical ciclosporin in nail psoriasis","volume":"180","author":"Tosti","year":"1990","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2005.07.073_bib92","first-page":"74","article-title":"Tacrolimus (FK 506): experience in dermatology","volume":"5","author":"Lawrence","year":"1998","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2005.07.073_bib93","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2133.1999.02974.x","article-title":"A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology","volume":"141","author":"Grassberger","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib94","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2133.1999.02927.x","article-title":"Tacrolimus ointment improves psoriasis in microplaque assay","volume":"141","author":"Remitz","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib95","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.1998.02554.x","article-title":"The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion","volume":"139","author":"Mrowietz","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib96","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.1973.tb02956.x","article-title":"Intradermal triamcinolone acetonide of nail dystrophies","volume":"89","author":"Abell","year":"1973","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib97","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2133.1974.tb06724.x","article-title":"Intralesional triamcinolone acetonide using the Port-o-jet and needle injections in localized dermatoses","volume":"91","author":"Bleeker","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib98","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2133.1976.tb15536.x","article-title":"The treatment of psoriatic nail dystrophy with intradermal steroid injections","volume":"95","author":"Peachey","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib99","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2133.1998.02031.x","article-title":"A simplified protocol of steroid injection for psoriatic nail dystrophy","volume":"138","author":"de Berker","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib100","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archderm.1962.01590100033009","article-title":"Psoriasis and lichen planus of nails","volume":"86","author":"Gerstein","year":"1962","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib101","series-title":"Current therapy","first-page":"664","article-title":"Disease of the nails","author":"Norton","year":"1982"},{"key":"10.1016\/j.jaad.2005.07.073_bib102","first-page":"357","article-title":"Treatment of psoriasis with a new UVB-lamp","volume":"69","author":"Larko","year":"1989","journal-title":"Acta Dermatol Venereol"},{"key":"10.1016\/j.jaad.2005.07.073_bib103","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0190-9622(99)70362-2","article-title":"Acitretin in combination with UVB or PUVA","volume":"41","author":"Lebwohl","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib104","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/0190-9622(91)70253-X","article-title":"Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study","volume":"25","author":"Tanew","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0190-9622(82)70005-2","article-title":"Combined methotrexate-PUVA therapy in the treatment of psoriasis","volume":"6","author":"Morison","year":"1982","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib106","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1751-1097.1975.tb06680.x","article-title":"Effects of 8-methoxypsoralen-induced phototoxic effects of mammailian epidermal macromolecule synthesis in vivo","volume":"24","author":"Epstein","year":"1975","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.jaad.2005.07.073_bib107","series-title":"Comprehensive dermatologic drug therapy","author":"Woverton","year":"2001"},{"key":"10.1016\/j.jaad.2005.07.073_bib108","series-title":"Photobiologic, toxicologic, and pharmacologic aspects of psoralens","article-title":"In vivo effects of psoralens plus longwave ultraviolet light radiation on immunity","author":"Morison","year":"1986"},{"key":"10.1016\/j.jaad.2005.07.073_bib109","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archderm.1980.01640330061013","article-title":"Response of psoriatic nails to oral photochemotherapy","volume":"116","author":"Marx","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2133.1987.tb05834.x","article-title":"Local PUVA treatment for nail psoriasis","volume":"116","author":"Handfield-Jones","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib111","first-page":"43","article-title":"Successful treatment of psoriasis of the nails","volume":"23","author":"Finnerty","year":"1979","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2005.07.073_bib112","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2340\/0001555572134136","article-title":"A double-blind study of superficial radiotherapy in psoriatic nail dystrophy","volume":"72","author":"Yu","year":"1992","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1016\/j.jaad.2005.07.073_bib113","first-page":"80","article-title":"Psoriasis of the nails treated with Grenz rays: a double-blind bilateral trial","volume":"69","author":"Lindel\u00f6f","year":"1989","journal-title":"Acta Dermatol Venereol"},{"key":"10.1016\/j.jaad.2005.07.073_bib114","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2340\/000155557590","article-title":"A therapeutic study of nail psoriasis using electron beams","volume":"75","author":"Kwang","year":"1995","journal-title":"Acta Dermatol Venereol"},{"key":"10.1016\/j.jaad.2005.07.073_bib115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0190-9622(95)90189-2","article-title":"Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement","volume":"32","author":"Mahrle","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib116","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2133.1993.tb03350.x","article-title":"van de Kerkhof PCM. Response of nail psoriasis to cyclosporine","volume":"129","author":"Arnold","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib117","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1021\/bi9627020","article-title":"The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptors and retinoid X receptor ligand binding domains","volume":"36","author":"Tian","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaad.2005.07.073_bib118","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/120347540400800208","article-title":"Nail psoriasis: combined therapy with systemic cyclosporine and topical calcipotriol","volume":"8","author":"Feliciani","year":"2004","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2005.07.073_bib119","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1001\/archderm.1997.03890480134028","article-title":"Cryotherapy for psoriasis","volume":"133","author":"Nouri","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archderm.1989.01670140079014","article-title":"Topical methotrexate therapy for psoriasis","volume":"125","author":"Weinstein","year":"1989","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib121","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1046\/j.1365-2133.2001.04246.x","article-title":"Topical application of mycophenolate mofetil in plaque-type psoriasis","volume":"144","author":"Wohlrab","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib122","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archderm.1990.01670280071013","article-title":"Sulfasalazine improves psoriasis. A double-blind analysis","volume":"126","author":"Gupta","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib123","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2133.1999.03034.x","article-title":"Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use","volume":"141","author":"Mrowietz","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib124","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1365-4362.1992.tb03548.x","article-title":"Azathioprine: a forgotten alternative for treatment of severe psoriasis","volume":"31","author":"Hecker","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib125","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJM199612263352615","article-title":"Accidental success with carbamazepine for psoriatic erythroderma","volume":"335","author":"Smith","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2005.07.073_bib126","first-page":"1070","article-title":"Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D3) for the treatment of psoriasis","volume":"134","author":"Perez","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.07.073_bib127","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-4362.1995.tb00635.x","article-title":"Low-dose oral propylthiouracil in the\u00a0treatment of plaque psoriasis","volume":"34","author":"Elias","year":"1995","journal-title":"Int J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205032287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205032287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:05:57Z","timestamp":1759269957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962205032287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":127,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0190962205032287"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2005.07.073","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis of the nail: Anatomy, pathology, clinical\u00a0presentation, and a review of the literature on therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2005.07.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}